Deng, Yihong

Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial

Noseworthy, P. A., Attia, Z. I., Behnken, E. M., Giblon, R. E., Bews, K. A., Liu, S., Gosse, T. A., Linn, Z. D., Deng, Y., Yin, J., et al. (2022) · The Lancet

Atrial Fibrillation Management and OutcomesECG Monitoring and Analysis

Cited by 257

Levothyroxine Use in the United States, 2008-2018

Brito, J. P., Ross, J. S., El Kawkgi, O. M., Maraka, S., Deng, Y., Shah, N. D., & Lipska, K. J. (2021) · JAMA Internal Medicine

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 94

Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk

McCoy, R. G., Herrin, J., Swarna, K. S., Deng, Y., Kent, D. M., Ross, J. S., Umpierrez, G. E., Galindo, R. J., Crown, W. H., Borah, B. J., et al. (2024) · Nature Cardiovascular Research

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 30

Association between generic-to-generic levothyroxine switching and thyrotropin levels among US adults.

Brito, J. P., Deng, Y., Ross, J. S., Choi, N. H., Graham, D. J., Qiang, Y., Rantou, E., Wang, Z., Zhao, L., Shah, N. D., et al. (2022) · JAMA Internal Medicine

Thyroid Disorders and TreatmentsPharmaceutical Economics and Policy

Cited by 29

Rates of, and factors associated with, switching among generic levothyroxine preparations in commercially insured American adults

Brito, J. P., Deng, Y., Ross, J. S., Choi, N. H., Graham, D. J., Qiang, Y., Rantou, E., Wang, Z., Zhao, L., Shah, N. D., et al. (2022) · Endocrine

Pharmaceutical Economics and PolicyThyroid Disorders and Treatments

Cited by 4